Partial agonism and independent modulation of T cell receptor and CD8 in hapten-specific cytotoxic T cells

European Journal of Immunology

Volumn 28, Issue 11, 1998, Pages 3706-3718

  Preckel, Tobias ^a   Breloer, Minka ^b   Kohler, Hubertus ^a   Von Bonin, Arne ^b   Weltzien, Hans Ulrich ^a  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Coreceptor; Lymphocyte; Nitrophenyl; Peptide; TCR down regulation

Indexed keywords

BREFELDIN A; CD8 ANTIGEN; GAMMA INTERFERON; HAPTEN; PARTIAL AGONIST; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION;

EID: 0031739790     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199811)28:11<3706::AID-IMMU3706>3.0.CO;2-7     Document Type: Article

References (50)

1. Qian, D. and Weiss, A., T cell antigen receptor signal transduction. Curr. Opin. Cell Biol. 1997. 9: 205-212.
2. Farber, D. L., Acuto, O. and Bottomly, K., Differential T-cell receptor mediated signaling in naive and memory CD4 T-cells. Eur. J. Immunol. 1997. 27: 2094-2101.
3. Madrenas, J. and Germain, R. N., Variant TCR ligands: new insights into the molecular basis of antigendependent signal transduction and T cell activation. Semin. Immunol. 1996. 8: 83-101.
4. Sloan Lancaster, J. and Allen, P. M., Altered peptide ligand-induced partial T-cell activation - molecular mechanisms and role in T-cell biology. Annu. Rev. Immunol. 1996. 14: 1-27.
5. Valitutti, S. and Lanzavecchia, A., A serial triggering model of TCR activation. Immunologist 1995. 3: 122-124.
6. Germain, R. N., T-cell signaling. The importance of receptor clustering. Curr. Biol. 1997. 7: 640-644.
7. Reich, Z., Boniface, J. J., Lyons, D. S., Borochov, N., Wachtel, E. J. and Davis, M. M., Ligand-specific oligomerization of T-cell receptor molecules. Nature 1997. 387: 617-620.
8. Rötzschke, O., Falk, K. and Strominger, J., Superactivation of an immune response triggered by oligomerized T cell epitopes. Proc. Natl. Acad. Sci. USA 1997. 94: 14642-14647.
9. Viola, A. and Lanzavecchia, A., T-cell activation determined by T-cell receptor number and tunable thresholds. Science 1996. 273: 104-106.
10. Preckel, T., Grimm, R., Martin, S. and Weltzien, H. U., Altered hapten ligands antagonize trinitrophenyl-specific cytotoxic T cells and block internalization of hapten-specific receptors. J. Exp. Med. 1997. 185: 1803-1813.
11. b-restricted TNP-epitopes. J. Immunol. 1993. 151: 678-687.
12. Martin, S., Ortmann, B., Pflugfelder, U., Birsner, U. and Weltzien, H. U., Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T-cells. Cross-reactive TNP-determinants on different peptides. J. Immunol. 1992. 149: 2569-2575.
13. Ortmann, B., Martin, S., von Bonin, A., Schiltz, E., Hoschützky, H. and Weltzien, H. U., Synthetic peptides anchor T cell-specific TNP epitopes to MHC antigens. J. Immunol. 1992. 148: 1445-1450.
14. Brossart, P. and Bevan, M. J., Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide. J. Exp. Med. 1996. 183: 2449-2458.
15. + T cells by a self-derived peptide. Nature 1995. 378: 295-298.
16. Bäckström, B. T., Rubin, B., Peter, A., Tiefenthaler, G. and Palmer, E., T cell receptor α-chain tail is required for protein kinase C-mediated down-regulation, but not for signaling. Eur. J. Immunol. 1997. 27: 1433-1441.
17. Viola, A., Salio, M., Tuosto, L., Linkert, S., Acuto, O. and Lanzavecchia, A., Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering. J. Exp. Med. 1997. 186: 1775-1779.
18. + T cells. J. Exp. Med. 1997. 185: 641-651.
19. Misumi, Y., Miki, K., Takatsuki, A., Tamura, G. and Ikehara, Y., Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J. Biol. Chem. 1986. 261: 11398-11403.
20. Obrig, T. G., Culp, W. J., McKeehan, W. L. and Hardesty, B., The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. J. Biol. Chem. 1971. 246: 174-181.
21. De Week, A. L., Drug allergy, immunotherapy, immune complexes and anaphylaxis. Curr. Opin. Immunol. 1990. 2: 548-557.
22. Kapsenberg, M. L., Bos, J. D. and Wierenga, E. A., T cells in allergic responses to haptens and proteins. Springer Semin. Immunopathol. 1992. 13: 303-314.
23. + T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur. J. Immunol. 1995. 25: 3006-3010.
24. + T cells. J. Exp. Med. 1996. 183: 1001-1012.
25. + T-cells. J. Immunol. 1997. 158: 4721-4728.
26. von Bonin, A., Ortmann, B., Martin, S. and Weltzien, H. U., Peptide-conjugated hapten-groups are the major antigenic determinants for trinitrophenyl-specific cytotoxic T cells. Int. Immunol. 1992. 4: 869-874.
27. d-restricted cloned CTL specific for a photoreactive peptide derivative. Immunity 1995. 3: 51-63.
28. Weltzien, H. U., Moulon, C., Martin, S., Padovan, E., Hartmann, U. and Kohler, J., T-cell immune-responses to haptens - structural models for allergic and autoimmune reactions. Toxicology 1996. 107: 141-151.
29. Vergelli, M., Hemmer, B., Kalbus, M., Vogt, A. B., Ling, N., Conlon, P., Coligan, J. E., McFarland, H. and Martin, R., Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells. J. Immunol. 1997. 158: 3746-3752.
30. Combadière, B., Reis e Sousa, C., Germain, R. N. and Lenardo, M. J., Selective induction of apoptosis in mature T lymphocytes by variant T cell receptor ligands. J. Exp. Med. 1998. 187: 349-355.
31. Bäckström, B. T., Milia, E., Peter, A., Jaureguiberry, B., Baldari, C. T. and Palmer, E., A motif within the TCR alpha chain constant region connecting peptide domain controls antigen responsiveness. Immunity 1996. 5: 437-447.
32. Jensen, W. A., Pleiman, C. M., Beaufils, P., Wegener, A. M. K., Malissen, B. and Gambier, J. C., Qualitatively distinct signaling through T-cell antigen receptor subunits. Eur. J. Immunol. 1997. 27: 707-716.
33. Wegener, A. M. K., Letourneur, F., Hoeveler, A., Brocker, T. Luton, F. and Malissen, B., The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell 1992. 68: 83-95.
34. + T cells. J. Exp. Med. 1997. 186: 757-766.
35. Kishimoto, H., Kubo, R. T., Yorifuji, H., Nakayama, T., Asano, Y. and Tada, T., Physical dissociation of the TCR-CD3 complex accompanies receptor ligation. J. Exp. Med. 1995. 182: 1997-2006.
36. Valitutti, S., Müller, S., Cella, M., Padovan, E. and Lanzavecchia, A., Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995. 375: 148-151.
37. Bachmann, M. F., Oxenius, A., Speiser, D. E., Mariathasan, S., Hengartner, H., Zinkernagel, R. M. and Ohashi, P. S., Peptide-induced T cell receptor down-regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation. Eur. J. Immunol. 1997. 27: 2195-2203.
38. + cytolytic T cells. Proc. Natl. Acad. Sci. USA 1990. 87: 9015-9019.
39. Jameson, S. C., Carbone, F. R. and Bevan, M., Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 1993. 177: 1541-1550.
40. Hampl, J., Chien, Y. H. and Davis, M. M., CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 1997. 7: 379-385.
41. Madrenas, J., Chau, L. A., Smith, J., Bluestone, J. A. and Germain, R. N., The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 1997. 185: 219-229.
42. Mannie, M. D., Rosser, J. M. and White, G. A., Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. J. Immunol. 1995. 154: 2642-2654.
43. Vidai, K., Hsu, B. L., Williams, C. B. and Alien, P. M., Endogenous altered peptide ligands can affect peripheral T cell responses. J. Exp. Med. 1996. 183: 1311-1321.
44. Weltzien, H. U., Kempkes, B., Studer, R., Melchers, I. and Eichmann, K., Growth-dependent variation of major histocompatibility complex (MHC) restriction and expression of Ly-2 and CD3/αβ T cell receptor in cloned cytotoxic T cells. Eur. J. Immunol. 1988. 18: 431-437.
45. Barnden, M. J., Heath, W. and Carbone, F. R., Down-modulation of CD8 β-chain in response to an altered peptide ligand enables developing thymocytes to escape negative selection. Cell. Immunol. 1997. 175: 111-119.
46. Jameson, S. C., Hogquist, K. A. and Bevan, M. J., Specificity and flexibility in thymic selection. Nature 1994. 369: 750-752.
47. Hämmerling, G. J., Schönrich, G., Ferber, I. and Arnold, B., Peripheral tolerance as a multi-step mechanism, Immunol. Rev. 1993. 133: 93-104.
48. Ljunggren, H. G. and Kärre, K., Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 1985. 162: 1745-1759.
49. Moore, F., Carbone, F. R. and Bevan, M. J., Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988. 54: 777-785.
50. Martin, S., Ruh, H., Hebbelmann, S., Pflugfelder, U., Rüde, B. and Weltzien, H. U., Carrier-reactive hapten-specific CTL clones originate from a highly preselected T cell repertoire: implications for chemical-induced self-reactivity. Eur. J. Immunol. 1995. 25: 2788-2796.